[Evidence based treatment of diabetic nephropathy].
Sugimoto
Toshiro
T
Third Department of Medicine, Shiga University of Medical Science.
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000628:therapy; D003928:Diabetic Nephropathies / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D018753:Diet, Protein-Restricted; D019317:Evidence-Based Medicine; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007004:Hypoglycemic Agents; D000077405:Irbesartan; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013777:Tetrazoles / Q000627:therapeutic use
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D007004:Hypoglycemic Agents; D013777:Tetrazoles; D000077405:Irbesartan